Many protein homeostasis stressors induce the formation of membraneless cytoplasmic stress 33 granules (SGs) that contain large assemblies of repressed mRNAs and associated RNA binding 34 proteins. Similar stressors have been shown to globally alter the function of the ubiquitin 35 proteasome system (UPS) resulting in the accumulation of ubiquitylated proteins. Previous 36 studies have demonstrated that ubiquitin and specific UPS components co-localize with SGs and 37 that reducing the abundance or activity of ubiquitin pathway proteins can inhibit SG formation. 38
Introduction 66
Protein homeostasis can be disrupted by a diverse array of intrinsic and extrinsic 67 stressors. Cellular insults such as oxidative and heat stress that globally disrupt protein folding 68 result in both the accumulation of ubiquitylated proteins, and the induction of membraneless 69 stress granules (SGs) have been demonstrated to delay disease progression in models of ALS and Alzheimer's 75 disease 6-9 . These findings have fueled studies aimed at identifying SG RNA and protein 76 constituents as potential modulators of SG dynamics and potential disease modifiers. 77
Genomic and proteomic characterization of both the SG RNA and protein constituents 78 have revealed a marked compositional diversity in both stress granule proteins and RNAs 8, 10, 11 . 79
Further, this diversity is altered by the exact stressor used to induce SGs as well as the cell type 80 in which SGs are examined 8 . Examination of SG proteomes has revealed that proteins involved 81 in regulating distinct post-translational modifications (PTMs) are often enriched within SGs. These 82 findings suggest that PTMs may either regulate global SG dynamics or the recruitment of 83 individual proteins into SGs 12 . For example, poly(ADP)-ribosylation was shown to regulate the SG 84 localization and biophysics of the well-characterized SG protein TDP43, and ablation of the 85 poly(ADP)-ribosylating enzyme, tankyrase, mitigated TDP43-assocaited toxicity in vivo 13 . These 86 studies indicate that targeting PTMs may be an effective strategy to alter SG dynamics. 87
Numerous lines of evidence have implicated protein ubiquitylation or other ubiquitin-like 88 modification systems, like neddylation, as a potential regulators of SG dynamics. First, 89 components of the ubiquitin-proteasome system (UPS), including ubiquitin itself, have been 90
shown to co-localize with SGs induced by a variety of protein homeostasis stressors [14] [15] [16] . Second, 91 proteasome inhibition and the concomitant increase in polyubiquitylated proteins results in SG 92 formation 15, 17, 18 . Third, genetic disruption or pharmacological inhibition of ubiquitin or neddylation 93 components can disrupt SG dynamics in both S. cerevisiae and mammalian cells 14, 16, [18] [19] [20] [21] [22] [23] . Despite 94 this evidence, several key questions regarding the role of ubiquitylation in regulating SG dynamics 95 remain unanswered. While ubiquitin has been shown to co-localize with SGs, whether 96 polyubiquitylated proteins themselves, or proteins modified with specific ubiquitin-linkages are 97 recruited to SGs is unknown. Further, SGs are variably induced by proteasome inhibition and 98 sustained treatment with the proteasome inhibitor MG132 results in SG dissolution over 99 time 15, 17, 18 . It is also unknown how many of the ubiquitin-system components that co-localize with 100
SGs, require ubiquitin within SGs for their localization. The deubiquitylating enzyme USP10 is a 101 well-characterized SG localized protein 21, 24 . However, USP10 SG localization is determined by 102 binding to another SG protein, G3BP1, and mutation of its active site, rendering it incapable of 103 removing ubiquitin from substrates, had little impact on its localization or overall SG dynamics 22,
104
25 . Despite the many links between the UPS and SGs, there has yet to be a demonstration that 105
Identification of resident SG protein ubiquitylation upon arsenite treatment 148
Our data, as well as previous reports, suggest that protein ubiquitylation may regulate overall SG 149 dynamics and the ability of specific proteins to localize to SGs upon protein homeostasis stress. 150
We utilized quantitative ubiquitin site-specific proteomic approaches to identify proteins whose 151 ubiquitylation status was altered upon arsenite treatment 26, 27 . HeLa cells grown in media 152 containing 13 C 15 N-labeled lysine were either untreated or treated with arsenite for 20 or 45 minutes 153 or were treated with arsenite for 45 minutes followed by washout and recovery for 3 hours. 154
Consistent with our previous results, arsenite treatment resulted in a global increase in protein 155 ubiquitylation which was reduced upon arsenite removal and recovery for 3 hours ( Fig. 2A,B , 156 Table S1 ). Arsenite treatment did not result in overt changes to protein abundance, at least for 157 the depth of proteome coverage achieved in this experiment. Greater than 35% of all ubiquitin-158 modified peptides quantified from cells treated with arsenite for 45 minutes increased or 159 decreased in abundance more than 2-fold indicating that a significant fraction of protein 160 ubiquitylation is impacted by arsenite treatment (Fig. 2C) . Modest, but consistent abundance 161 increases in all but lysine11(K11)-linked ubiquitin-chains were observed upon 45-minute arsenite 162 treatment which were reduced during arsenite washout and recovery (Fig. 2D) . Interestingly, K63-163 linked ubiquitin chains also increased upon arsenite treatment which suggests that regulatory 164 protein ubiquitylation that does not target proteins for degradation may be involved in the 165 response to arsenite-induced oxidative stress, and by extension, SG dynamics. We utilized a 166 curated list of validated SG resident proteins to directly examine if known SG proteins were 167 selectively ubiquitylated upon arsenite treatment ( Table S2 ). The abundance of 102 ubiquitylated 168 peptides across 43 known SG proteins was not significantly altered upon arsenite treatment or 169 washout compared to untreated samples indicating that, at least taken together, SG resident 170 protein ubiquitylation was not specifically altered during conditions that induce SG formation (Fig.  171  2E) . However, examination of individual SG proteins revealed known SG proteins with multiple 172 ubiquitylation events that either robustly increased (HNRNPK) or decreased (RPS3, PABPC4) 173 upon arsenite treatment (Fig. 2F) . Our data suggest that while SG protein ubiquitylation is not 174 globally impacted by arsenite treatment, it remains possible that the ubiquitylation of specific SG 175 proteins govern their SG localization. 176
Acute pharmacological inhibition of the ubiquitin activating enzyme results in a rapid loss of 177 protein ubiquitylation. 178
Ubiquitin has been observed to co-localize with SGs and ubiquitin system components have been 179 demonstrated to both localize to SGs and regulate SG dynamics implicating a role for protein 180 ubiquitylation during SG formation or dissolution. However, a direct evaluation of whether active 181 protein ubiquitylation is required to either form or resolve SGs has not been reported. To perform 182 such an examination, we utilized a newly developed specific and potent ubiquitin E1 activating 183 enzyme (UAE) inhibitor (TAK-243, also known as MLN7243) to acutely inhibit protein 184 ubiquitylation 28 . We first determined the concentration and time dependence on the reduction of 185 protein ubiquitylation upon TAK-243 (which we refer to as Ub-E1i) treatment. Addition of 186 increasing amounts of Ub-E1i to HCT116 cells for 4 hours resulted in a dose-dependent decrease 187 in polyubiquitylated proteins with complete abrogation of observable polyubiquitylated material 188 with Ub-E1i treatment above 0.5µM (Fig. 3A) . Proteasome inhibition resulted in the wellcharacterized increase in total protein ubiquitylation which was completely blocked upon co-190 treatment with Ub-E1i. Ub-E1i addition resulted in time-dependent decrease in polyubiquitylated 191 material, and consistent with previous reports, Ub-E1i treatment was selective for UAE as cullin 192 neddylation was unaffected after 4 hours of Ub-E1i treatment but was completely blocked by 193 addition of the Nedd8 activating enzyme (NAE) inhibitor MLN4924 (TAK-924 which we refer to as 194 N8-E1i) (Fig. 3A,B) 29 Table S3 ). More than 80% of all quantified ubiquitin-modified peptides were reduced 205 in abundance more than 1.7-fold with or without MG132 treatment (Fig. 3C,D) . As observed with 206 proteasome inhibition alone, UAE inactivation had little impact on overall protein abundance after 207 4 hours of treatment (Fig. 3C, Table S3 ). However, a more complete characterization of low 208 abundance proteins would likely reveal robust protein abundance alterations. As would be 209 predicted upon UAE inhibition, all detected ubiquitin-linkage peptides were reduced more than 8-210
fold, indicating that Ub-E1i treatment severely reduces total protein polyubiquitylation regardless 211 of chain type (Fig. 3E) . A direct examination of the ubiquitylation status of known SG proteins 212 revealed that Ub-E1i treatment, like observed for more than 80% of all ubiquitylated peptides, 213 resulted in a clear reduction of SG protein ubiquitylation across a diversity of individual 214 ubiquitylation sites (Fig. 3F) . Interestingly, a subset of diGly-modified peptides were refractory to 215 UAE inactivation (Fig. 3C,D) . These peptides either arise from neddylation or their ubiquitylation 216 is not rapidly reversible upon UAE inactivation. Regardless, our results demonstrate that Ub-E1i 217 treatment results in the rapid loss of greater than 80% of all ubiquitylation events. 218
Active protein ubiquitylation or neddylation is not required for SG formation or dissolution 219
Having established UAE inactivation via Ub-E1i treatment as a powerful tool to rapidly and 220 robustly ablate protein ubiquitylation and probe the dependence of any pathway on active protein 221 ubiquitylation, we set out to test if SG formation or dissolution required protein ubiquitylation. We 222 first utilized a previously characterized 293T cell line expressing the well-established SG protein, 223 G3BP1, tagged with GFP at its endogenous C-terminus using CRISPR/Cas9-based approaches 8 . 224
Consistent with previous results, arsenite addition resulted in a rapid increase in SG formation as 225 determined by G3BP1-GFP coalescence (Fig. 4A,B) . Pre-treatment with Ub-E1i followed by 226 treatment with two different concentrations of arsenite did not delay the kinetics of SG formation 227 over a 2-hour time course (Fig. 4A,B, S1A,B) . At 100µM arsenite, Ub-E1i addition resulted in a 228 small enhancement of SG formation at early time points, indicating that the added stress of UAE 229 inhibition may accelerate SG formation for lower concentrations of arsenite. Pre-treatment with 230 the NAE inhibitor MLN4924 (N8-E1i) followed by arsenite treatment did not affect SG formation 231 at either of the tested arsenite concentrations (Fig. 4A,B, S1A,B) . Addition of either Ub-E1i orN8-E1i alone did not induce SG formation (Fig. S1A) . Taken together, these observations indicate 233 that neither active protein ubiquitylation nor neddylation are required for initial arsenite-induced 234 SG formation. We then determined if protein ubiquitylation or neddylation was required for SG 235 dissolution following arsenite removal. 293T G3BP1-GFP cells were pre-treated with DMSO, Ub-236
E1i, or N8-E1i for 1 hour and SGs were formed by treatment with arsenite in the presence of 237 inhibitors for 1 hour. SG dissolution was monitored after arsenite washout in media that lacked 238
Ub-E1i or N8-E1i. While NAE inhibition has no measurable impact on SG dissolution, Ub-E1i 239 addition resulted in a minor delay in SG dissolution (Fig. 4C,D) . We validated these results in 240
HeLa cells using G3BP1 antibodies to monitor SG formation and clearance. As observed in 293T 241 cells, UAE inhibition did not delay the kinetics of arsenite-induced SG formation using two different 242 arsenite concentrations, with a slight acceleration of SG formation at early time points (Fig. 4E,F , 243 S1C). We were unable to validate the small delay in SG dissolution upon Ub-E1i treatment seen 244 in 293T cells as UAE inactivation had no impact on SG clearance in HeLa cells (Fig. 4G,H, S1D) . 245
Taken together, our results clearly indicate that acute inhibition of protein ubiquitylation or 246 neddylation has little to no impact on SG dynamics. 247
Unconjugated ubiquitin co-localizes with SGs in a UAE independent manner. 248
In accordance with previous studies, we were able to show that ubiquitin co-localizes with SGs 249 using immunofluorescence techniques (Fig. 1E) . Because ubiquitin exists in a variety of 250 biochemically distinct pools within cells (e.g. unconjugated "free" ubiquitin and lysine-48 linked 251 polyubiquitin chains) 30 , we set out to carefully characterize which forms of ubiquitin specifically 252 co-localize with SGs. As detailed earlier, sodium arsenite treatment in three cell types resulted in 253 robust co-localization of SGs with ubiquitin using a pan-ubiquitin antibody that recognizes both 254 unconjugated and conjugated ubiquitin (Fig. 1A) . Staining with two different ubiquitin antibodies 255
shown to have a preference for polyubiquitin chains under denaturing PAGE-western blotting 256 conditions revealed only modest co-localization of polyubiquitin with SGs in both HeLa and U2OS 257 cells (Fig. 5A,B) 31 . However, the co-localization with SGs was far weaker than compared to the 258 pan-ubiquitin signal (Fig. 1E) , suggesting that most of the ubiquitin in SGs represents either free 259 ubiquitin or monoubiquitylated proteins. Interestingly, increasing the length of arsenite exposure 260 in HeLa cells (2h at 250uM) resulted in co-localization of the FK1 and FK2 immunofluoresence 261 signal with juxta-nuclear inclusion bodies reminiscent of aggresomes (Fig. 5B) 32 . These 262 inclusions were rarely seen with shorter exposures to arsenite (30min at 250uM) and were not 263 prominently stained by the pan-ubiquitin antibody (Fig. 5B) 
. Treatment of HeLa cells with the Ub-264
E1i prior to SG induction did not alter SG formation and the pan-ubiquitin signal was unaffected. 265
In contrast, overall staining intensity with FK1 and FK2 antibodies was significantly reduced (Fig.  266  5B) . Interestingly, while co-localization of the FK1 and FK2 signal with aggresomes disappeared 267 completely upon Ub-E1i treatment, most of the remaining signal clearly co-localized with SGs 268 (Fig. 5B) . These data suggest that both FK1 and FK2 can recognize free ubiquitin under 269 immunofluorescence conditions, especially when the cellular pool of free ubiquitin is increased by 270 the near complete ablation of polyubiquitin conjugates upon UAE inhibition. This result further 271 supports the hypothesis that the ubiquitin pool that co-localizes with SGs consists primarily of 272 unconjugated ubiquitin or monoubiquitylated proteins. To further substantiate these claims, we 273 performed immunofluorescence staining with two antibodies that specifically recognize either 274 K48-or K63-linked poly-ubiquitin chains 33 . Indeed, the signals from both K48-and K63-specific 275 antibodies (Apu2 and Apu3, respectively) do not co-localize with arsenite-induced SGs, but 276 instead label the same presumptive aggresome structures seen with FK1 and FK2 antibodies in 277 a time-dependent manner (Fig. 5C, S2 ). As expected, Ub-E1i treatment ablated both K48 and 278 K63 signals, reinforcing the linkage specificity of these antibodies and their inability to recognize 279 free ubiquitin (Fig. 5C, S2) .
281
To test the generality of our observations, we induced SG formation using thapsigargin 282 (Tg) treatment of U2OS cells and examined pan-ubiquitin and polyubiquitin localization. Similar 283 to arsenite-induced SGs, the pan-ubiquitin signal co-localized clearly with Tg-induced SGs and 284 was not substantially altered by UAE inhibition in U2OS cells (Fig, 5A,D) . By contrast, 285 immunofluorescence staining with the FK2 antibody revealed a complete lack of co-localization 286 between the presumptive polyubiquitin signal with Tg-induced SGs, and UAE inhibition resulted 287 in a dramatic reduction of the FK2 signal (Fig. 5D) 20, 21 . Near complete NAE inhibition using the N8-E1i takes place on minute 312 timescales when added to mammalian cells 45 . As such, it is critical to separate observations using 313 acute NAE or UAE inhibition with those using prolonged inhibition that will result in widespread 314 cellular dysfunction. Our observation that ubiquitin remains co-localized with SGs even after acute 315 UAE inhibition suggests that free, unconjugated ubiquitin may play a role in nucleating SGs. 316
Consistent with this hypothesis is the demonstration that the ubiquitin binding protein UBQLN2 317 undergoes LLPS in vitro and that this transition can be inhibited by adding unconjugated ubiquitin 318 to the reaction 46 . It will be difficult to demonstrate that free ubiquitin is critical for SG dynamics 319
given the inability to ablate cellular ubiquitin without catastrophic consequences to overall cellular 320 
Antibodies, Chemicals, and Plasmids 339
The following antibodies were utilized in this study. Antibodies for α-tubulin (3873), and Phospho-340 eIF2a (Ser51, 3398) were from Cell Signaling Technology. G3BP1 antibody was from MBL 341 were diluted in blocking buffer and incubated overnight at 4˚C, followed by 2 washes in PBST, 364 counterstaining of nuclei with DAPI and two final washes in PBS. Cells were then imaged at 20X 365 magnification on a ZEISS Axio Vert.A1 inverted microscope and images were processed using 366
ImageJ. 367 368

High-content imaging of SG time course plates. 369
96-or 384-well plates were imaged using a Vala Sciences IC200-KIC high-content screening 370 system. Either four or nine fields at the center of each well were imaged with a 20X objective 371 through 460 nm and 535 nm emission filters for DAPI and G3BP1-GFP, respectively. Exposure 372 times were optimized for each set of plates and applied uniformly to all wells. 373 374
Automated image segmentation and feature quantification 375
Images from SG assembly and disassembly time courses were segmented and image features 376 quantified using a custom CellProfiler pipeline 49 . Briefly, nuclei were segmented and identified in 377 the DAPI fluorescence channel images using a diameter cutoff of 9-80 pixels for HEK293xT and 378
HeLa cells. Cell bodies were then extrapolated by overlaying the GFP fluorescence channel 379 images and tracing radially outward from the nuclei to the limits of the cytoplasmic G3BP1-GFP 380 signal. The cell bodies were used as masks to eliminate imaging artifacts outside of cell 381 boundaries, such as background fluorescence or dead cells. After masking, punctate structures 382 were enhanced by image processing for speckle-like features that were 10 pixels in diameter for 383
HEK293xT and HeLa cells, and these punctate structures were then annotated as stress 384 granules. Finally, feature count and total feature area for nuclei and stress granules were 385 calculated and exported for statistical analysis. To quantify SG dynamics, the total area covered 386 
Mass Spectrometry 393
Heavy and light labeled cells were mixed 1:1 and processed for proteomics and diGLY-immuno-394 affinity enrichment as described previously 26, 27 . Samples were analyzed by LC-MS/MS using a 395 Q-Exactive mass spectrometer (Thermo Scientific, San Jose, CA) and all data was processed as 396 described previously 26 . All RAW mass spectrometry data files have been deposited at the 397 MassIVE repository using the accession identifier MSV000082933. E) The indicated cell lines were treated with sodium arsenite (500µM for 1h). Cells were then 427 fixed, and stress granules were localized by G3BP1 immunofluorescence or using G3BP1-GFP 428 fluorescence for 293 cells (green). Ubi-1 antibody staining was used to localize ubiquitin (red). with heavy-labeled Ub-E1i-treated cells and whole cell lysates were generated and digested with 467 trypsin. Ubiquitin-modified peptides (diGLY peptides) were immuno-isolated and both diGLY-468 modified peptides and total peptides were analyzed by mass spectrometry. The log2 heavy to 469 light ratios are depicted for all diGLY-modified peptides (top) and total proteins (bottom) for each 470
sample. 471
D) The fraction of all quantified diGLY-modified peptides that increased or decreased in 472 abundance greater than 1.7-fold or were unaltered upon Ub-E1i treatment with or without 473 proteasome inhibition. 474
E) The log2 heavy to light ratio corresponding to diGLY-modified peptides from ubiquitin after Ub-475
E1i treatment alone. The individual ubiquitin-modified lysine that was quantified is indicated. Error 476 bars denote SEM of multiple quantification events for a given peptide. 477
F) The log2 ratio of all diGLY-modified peptides quantified from known stress granule proteins is 478 depicted after Ub-E1i treatment with or without proteasome inhibition. 479 480 E) Hela cells were pre-treated with DMSO or Ub-E1i for 90' followed by treatment with sodium 497 arsenite (500µM) for the indicated times. Cells were fixed, SGs were localized using G3BP1 498 immunofluorescence, cells were imaged, and SG and nuclear area was quantified at the indicated 499 times. 500 F) Representative images for the indicated time points and treatments quantified in panel E. 501 G) Hela cells were pre-treated with DMSO or Ub-E1i for 90' followed by treatment with sodium 502 arsenite (250µM) for 60' at which time the sodium arsenite and Ub-E1i was washed out and cells 503 were fixed and imaged at the indicated times following sodium arsenite washout. Cells were fixed, 504
SGs were localized using G3BP1 immunofluorescence, cells were imaged, and SG and nuclear 505 area was quantified at the indicated times. Error bars depict standard deviation of the mean. followed by treatment with sodium arsenite (250µM) for 120' prior to fixation. Cells were stained 520 using an antibody against G3BP1 (green) and the indicated antibodies against ubiquitin (red). 521 G3BP1-negative juxtanuclear aggresomes are indicated by closed arrowheads. 522 C) Immunofluorescence staining of HeLa cells pretreated with DMSO or Ub-E1i (2.5µM) for 60', 523 followed by treatment with sodium arsenite (250µM) for 120' prior to fixation. Cells were stained 524 using an antibody against G3BP1 (green) and linkage-specific antibodies against K48-and K63-525 linked polyubiquitin chains (red). G3BP1-negative juxtanuclear aggresomes are indicated by 526 closed arrowheads. 527 D) Immunofluorescence staining of U2OS cells pretreated with DMSO or Ub-E1i (2.5µM) for 60', 528 followed by treatment with thapsigargin (1µM) for 60' prior to fixation. Cells were stained using an 529 antibody against G3BP1 (green) and the indicated ubiquitin antibodies (red). Images from Ub-530
E1i-treated cells in panels (B), (C), and (D) were taken at the same exposure time and acquisition 531 settings in the ubiquitin channel as images from DMSO-treated cells. Nuclei in all panels were 532 stained using DAPI. Scale bars = 20µm in all panels. 533 534
Supplementary Information 536 537
Figure S1 -Stress granule dynamics are unaffected by inhibition of protein ubiquitylation 538 or neddylation. 539 A) 293T cells expressing GFP-tagged G3BP1 were pre-treated for 90' with DMSO (blue bars), 540
Ub-E1i (red bars), or N8-E1i (green bars) followed by treatment with (black circles) or without 541 (white circles) sodium arsenite (500µM) for the indicated times. Cells were fixed and imaged at 542 the indicated times. 543 B) 293T cells expressing GFP-tagged G3BP1 were pre-treated for 90' with DMSO (blue bars), 544
Ub-E1i (red bars), or N8-E1i (green bars) followed by treatment with sodium arsenite (100µM) for 545 the indicated times. Cells were fixed and imaged at the indicated times. 546 C) Hela cells were pre-treated with DMSO or Ub-E1i for 90' followed by treatment with sodium 547 arsenite (100µM) for the indicated times. Cells were fixed and SGs were localized using G3BP1 548 immunofluorescence. 549 D) Hela cells were pre-treated with DMSO or Ub-E1i for 90' followed by treatment with sodium 550 arsenite (100µM) for 60' at which time the sodium arsenite was washed out and cells were fixed 551 at the indicated times following sodium arsenite washout. SGs were localized using G3BP1 552 immunofluorescence. For all panels, the stress granule and nuclear area was quantified using 553 custom image analysis scripts for the indicated time points and treatments. Error bars depict 554 standard deviation of the mean. The curated list of previously determined SG-localized proteins used for all proteomic analysis of 573 known SG proteins. 574 575 Table S3 -Alterations to the proteome and ubiquitin-modified proteome upon UAE 576 inhibition. 577 Table of 
